The two-state dimer receptor model: a general model for receptor dimers - PubMed (original) (raw)
. 2006 Jun;69(6):1905-12.
doi: 10.1124/mol.105.020685. Epub 2006 Feb 24.
Affiliations
- PMID: 16501032
- DOI: 10.1124/mol.105.020685
The two-state dimer receptor model: a general model for receptor dimers
Rafael Franco et al. Mol Pharmacol. 2006 Jun.
Abstract
Nonlinear Scatchard plots are often found for agonist binding to G-protein-coupled receptors. Because there is clear evidence of receptor dimerization, these nonlinear Scatchard plots can reflect cooperativity on agonist binding to the two binding sites in the dimer. According to this, the "two-state dimer receptor model" has been recently derived. In this article, the performance of the model has been analyzed in fitting data of agonist binding to A(1) adenosine receptors, which are an example of receptor displaying concave downward Scatchard plots. Analysis of agonist/antagonist competition data for dopamine D(1) receptors using the two-state dimer receptor model has also been performed. Although fitting to the two-state dimer receptor model was similar to the fitting to the "two-independent-site receptor model", the former is simpler, and a discrimination test selects the two-state dimer receptor model as the best. This model was also very robust in fitting data of estrogen binding to the estrogen receptor, for which Scatchard plots are concave upward. On the one hand, the model would predict the already demonstrated existence of estrogen receptor dimers. On the other hand, the model would predict that concave upward Scatchard plots reflect positive cooperativity, which can be neither predicted nor explained by assuming the existence of two different affinity states. In summary, the two-state dimer receptor model is good for fitting data of binding to dimeric receptors displaying either linear, concave upward, or concave downward Scatchard plots.
Similar articles
- Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation.
Casadó V, Ferrada C, Bonaventura J, Gracia E, Mallol J, Canela EI, Lluís C, Cortés A, Franco R. Casadó V, et al. Biochem Pharmacol. 2009 Dec 15;78(12):1456-63. doi: 10.1016/j.bcp.2009.07.012. Epub 2009 Jul 28. Biochem Pharmacol. 2009. PMID: 19643089 - Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding.
Albizu L, Balestre MN, Breton C, Pin JP, Manning M, Mouillac B, Barberis C, Durroux T. Albizu L, et al. Mol Pharmacol. 2006 Nov;70(5):1783-91. doi: 10.1124/mol.106.025684. Epub 2006 Aug 22. Mol Pharmacol. 2006. PMID: 16926282 - Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.
Casadó V, Cortés A, Ciruela F, Mallol J, Ferré S, Lluis C, Canela EI, Franco R. Casadó V, et al. Pharmacol Ther. 2007 Dec;116(3):343-54. doi: 10.1016/j.pharmthera.2007.05.010. Epub 2007 Jun 14. Pharmacol Ther. 2007. PMID: 17935788 Review. - Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.
Damian M, Martin A, Mesnier D, Pin JP, Banères JL. Damian M, et al. EMBO J. 2006 Dec 13;25(24):5693-702. doi: 10.1038/sj.emboj.7601449. Epub 2006 Nov 30. EMBO J. 2006. PMID: 17139258 Free PMC article. - Allosteric functioning of dimeric class C G-protein-coupled receptors.
Pin JP, Kniazeff J, Liu J, Binet V, Goudet C, Rondard P, Prézeau L. Pin JP, et al. FEBS J. 2005 Jun;272(12):2947-55. doi: 10.1111/j.1742-4658.2005.04728.x. FEBS J. 2005. PMID: 15955055 Review.
Cited by
- Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
Kenakin T, Miller LJ. Kenakin T, et al. Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14. Pharmacol Rev. 2010. PMID: 20392808 Free PMC article. Review. - Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics.
May LT, Bridge LJ, Stoddart LA, Briddon SJ, Hill SJ. May LT, et al. FASEB J. 2011 Oct;25(10):3465-76. doi: 10.1096/fj.11-186296. Epub 2011 Jun 29. FASEB J. 2011. PMID: 21715680 Free PMC article. - Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.
Ferrada C, Moreno E, Casadó V, Bongers G, Cortés A, Mallol J, Canela EI, Leurs R, Ferré S, Lluís C, Franco R. Ferrada C, et al. Br J Pharmacol. 2009 May;157(1):64-75. doi: 10.1111/j.1476-5381.2009.00152.x. Br J Pharmacol. 2009. PMID: 19413572 Free PMC article. - Understanding the added value of g-protein-coupled receptor heteromers.
Franco N, Franco R. Franco N, et al. Scientifica (Cairo). 2014;2014:362937. doi: 10.1155/2014/362937. Epub 2014 Apr 22. Scientifica (Cairo). 2014. PMID: 24864225 Free PMC article. Review. - Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins.
Franco R, Lluis C, Canela EI, Mallol J, Agnati L, Casadó V, Ciruela F, Ferré S, Fuxe K. Franco R, et al. J Neural Transm (Vienna). 2007 Jan;114(1):93-104. doi: 10.1007/s00702-006-0566-7. Epub 2006 Oct 6. J Neural Transm (Vienna). 2007. PMID: 17024327 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources